Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

40
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
40
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

298
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
298
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

424
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
424
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.0K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

649
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
649

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bright nanoparticle-labeled lateral flow immunoassay for rapid quantitative detection of tacrolimus in human plasma.

Mikrochimica acta·2025
Same author

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model.

Journal of visualized experiments : JoVE·2025
Same author

An interpretable machine learning model based on optimal feature selection for identifying CT abnormalities in patients with mild traumatic brain injury.

EClinicalMedicine·2025
Same author

Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinoma.

Frontiers in immunology·2025
Same author

Serum Albumin Levels and Length of Stay in Premature Infants.

Indian journal of pediatrics·2025
Same author

A novel role of the antidepressant paroxetine in inhibiting neuronal Kv7/M channels to enhance neuronal excitability.

Translational psychiatry·2025

相关实验视频

Updated: Feb 26, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K

CL-MHAD:基于对比学习的多重字汇总和扩散模型,用于处方建议.

Juanzi Zhou1, Yin Zhang2, Fang Hu1

  • 1College of Information Engineering, Hubei University of Chinese Medicine, Wuhan, 430065, China.

Artificial intelligence in medicine
|February 24, 2026
PubMed
概括
此摘要是机器生成的。

这项研究介绍了CL-MHAD,这是传统中医药 (TCM) 处方建议的新型模型. 它通过有效地融合多维草药知识以实现个性化的诊断和治疗来提高准确性.

关键词:
交叉视图对比学习学习数据增强数据增强功能融合的特点是:超图集和扩散的聚合和扩散.损失函数的重建损失函数的重建处方建议建议的建议

更多相关视频

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.2K

相关实验视频

Last Updated: Feb 26, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.7K
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

1.2K

科学领域:

  • 人工智能的人工智能
  • 计算生物学 计算生物学
  • 传统中国医学 (TCM) 是一种

背景情况:

  • 在TCM中,个性化诊断和治疗依赖于基于综合征的处方建议.
  • 为准确的TCM建议提取和融合多维草药知识是一项挑战.

研究的目的:

  • 提出CL-MHAD,一种基于对比学习的多重图汇总和扩散模型,用于改进TCM处方建议.
  • 为应对有效提取和融合多维草药知识的挑战.

主要方法:

  • 开发了一种多视图超图重建机制,专注于处方,草药,特性和剂量.
  • 实施了一种扩散增强的方法来捕捉高阶关系和交叉视图对比学习策略.
  • 利用拓意识的随机步行增强来减轻数据稀疏性和一个集成的损失函数用于优化.

主要成果:

  • 在实际的胃肠道疾病 (GID) 临床环境中,CL-MHAD在基线模型中表现出优越的性能.
  • 在多个评估指标中实现了从1.27%到24.67%的绩效增长.
  • 验证了加权聚变战略的有效性和模型在数据稀疏性方面的稳定性.

结论:

  • 在TCM中,CL-MHAD为基于综合征的准确处方建议提供了一个有效的解决方案.
  • 拟议的模型为推进TCM个性化医学提供了一个有希望的范式.